265 related articles for article (PubMed ID: 24486470)
1. The time-dependent effect of ibandronate on bone graft remodeling in an ovariectomized rat spinal arthrodesis model.
Park SB; Park SH; Kang YK; Chung CK
Spine J; 2014 Aug; 14(8):1748-57. PubMed ID: 24486470
[TBL] [Abstract][Full Text] [Related]
2. Effect of a selective estrogen receptor modulator on bone formation in osteoporotic spine fusion using an ovariectomized rat model.
Park SB; Kim CH; Hong M; Yang HJ; Chung CK
Spine J; 2016 Jan; 16(1):72-81. PubMed ID: 26343247
[TBL] [Abstract][Full Text] [Related]
3. The bisphosphonate ibandronate improves implant integration in osteopenic ovariectomized rats.
Kurth AH; Eberhardt C; Müller S; Steinacker M; Schwarz M; Bauss F
Bone; 2005 Aug; 37(2):204-10. PubMed ID: 15936997
[TBL] [Abstract][Full Text] [Related]
4. The effect of anti-resorptive therapies on bone graft healing in an ovariectomized rat spinal arthrodesis model.
Takahata M; Ito M; Abe Y; Abumi K; Minami A
Bone; 2008 Dec; 43(6):1057-66. PubMed ID: 18835375
[TBL] [Abstract][Full Text] [Related]
5. The influence of alendronate on spine fusion in an osteoporotic animal model.
Nakao S; Minamide A; Kawakami M; Boden SD; Yoshida M
Spine (Phila Pa 1976); 2011 Aug; 36(18):1446-52. PubMed ID: 21240048
[TBL] [Abstract][Full Text] [Related]
6. Effect of zoledronic acid on spinal fusion outcomes in an ovariectomized rat model of osteoporosis.
Yasen M; Li X; Jiang L; Yuan W; Che W; Dong J
J Orthop Res; 2015 Sep; 33(9):1297-304. PubMed ID: 26011820
[TBL] [Abstract][Full Text] [Related]
7. Intermittent administration of teriparatide enhances graft bone healing and accelerates spinal fusion in rats with glucocorticoid-induced osteoporosis.
Sugiura T; Kashii M; Matsuo Y; Morimoto T; Honda H; Kaito T; Iwasaki M; Yoshikawa H
Spine J; 2015 Feb; 15(2):298-306. PubMed ID: 25110274
[TBL] [Abstract][Full Text] [Related]
8. The effect of therapies for osteoporosis on spine fusion: a systematic review.
Hirsch BP; Unnanuntana A; Cunningham ME; Lane JM
Spine J; 2013 Feb; 13(2):190-9. PubMed ID: 22658879
[TBL] [Abstract][Full Text] [Related]
9. BMP-2 induced early bone formation in spine fusion using rat ovariectomy osteoporosis model.
Park SB; Park SH; Kim NH; Chung CK
Spine J; 2013 Oct; 13(10):1273-80. PubMed ID: 23953506
[TBL] [Abstract][Full Text] [Related]
10. Zoledronic acid suppresses callus remodeling but enhances callus strength in an osteoporotic rat model of fracture healing.
Hao Y; Wang X; Wang L; Lu Y; Mao Z; Ge S; Dai K
Bone; 2015 Dec; 81():702-711. PubMed ID: 26434668
[TBL] [Abstract][Full Text] [Related]
11. Ibandronate does not reduce the anabolic effects of PTH in ovariectomized rat tibiae: a microarchitectural and mechanical study.
Yang X; Chan YH; Muthukumaran P; Dasde S; Teoh SH; Lee T
Bone; 2011 May; 48(5):1154-63. PubMed ID: 21334474
[TBL] [Abstract][Full Text] [Related]
12. Intermittent Ibandronate Maintains Bone Mass, Bone Structure, and Biomechanical Strength of Trabecular and Cortical Bone After Discontinuation of Parathyroid Hormone Treatment in Ovariectomized Rats.
Takeda S; Sakai S; Tanaka K; Tomizawa H; Serizawa K; Yogo K; Urayama K; Hashimoto J; Endo K; Matsumoto Y
Calcif Tissue Int; 2017 Jul; 101(1):65-74. PubMed ID: 28246925
[TBL] [Abstract][Full Text] [Related]
13. Effect of a bisphosphonate and selective estrogen receptor modulator on bone remodeling in streptozotocin-induced diabetes and ovariectomized rat model.
Lee YS; Gupta R; Kwon JT; Cho DC; Seo YJ; Seu SY; Park EK; Han I; Kim CH; Sung JK; Kim KT
Spine J; 2018 Oct; 18(10):1877-1887. PubMed ID: 29793000
[TBL] [Abstract][Full Text] [Related]
14. Combination treatment with eldecalcitol (ED-71) and raloxifene improves bone mechanical strength by suppressing bone turnover and increasing bone mineral density in ovariectomized rats.
Takeda S; Sakai S; Shiraishi A; Koike N; Mihara M; Endo K
Bone; 2013 Mar; 53(1):167-73. PubMed ID: 23232307
[TBL] [Abstract][Full Text] [Related]
15. Intermittent ibandronate preserves bone quality and bone strength in the lumbar spine after 16 months of treatment in the ovariectomized cynomolgus monkey.
Müller R; Hannan M; Smith SY; Bauss F
J Bone Miner Res; 2004 Nov; 19(11):1787-96. PubMed ID: 15476578
[TBL] [Abstract][Full Text] [Related]
16. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
[TBL] [Abstract][Full Text] [Related]
17. Treatment with the combination of ibandronate plus eldecalcitol has a synergistic effect on inhibition of bone resorption without suppressing bone formation in ovariectomized rats.
Sakai S; Takeda S; Sugimoto M; Shimizu M; Shimonaka Y; Yogo K; Hashimoto J; Bauss F; Endo K
Bone; 2015 Dec; 81():449-458. PubMed ID: 26281770
[TBL] [Abstract][Full Text] [Related]
18. Effects of treatment with ibandronate on bone mass, architecture, biomechanical properties, and bone concentration of ibandronate in ovariectomized aged rats.
Bauss F; Lalla S; Endele R; Hothorn LA
J Rheumatol; 2002 Oct; 29(10):2200-8. PubMed ID: 12375334
[TBL] [Abstract][Full Text] [Related]
19. Antiosteoporotic activity of Du-Zhong-Wan water extract in ovariectomized rats.
Li F; Yang X; Bi J; Yang Z; Zhang C
Pharm Biol; 2016 Sep; 54(9):1857-64. PubMed ID: 26760929
[TBL] [Abstract][Full Text] [Related]
20. Alendronate Prevents Intervertebral Disc Degeneration Adjacent to a Lumbar Fusion in Ovariectomized Rats.
Zhou Z; Tian FM; Wang P; Gou Y; Zhang H; Song HP; Wang WY; Zhang L
Spine (Phila Pa 1976); 2015 Oct; 40(20):E1073-83. PubMed ID: 26731708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
